Verve Therapeutics Stock Technical Analysis
| VERV Stock | USD 6.23 0.07 1.11% |
As of the 14th of December 2024, Verve Therapeutics has the Risk Adjusted Performance of 0.0396, coefficient of variation of 2347.71, and Semi Deviation of 4.26. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verve Therapeutics, as well as the relationship between them. Please validate Verve Therapeutics jensen alpha and semi variance to decide if Verve Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 6.23 per share. Given that Verve Therapeutics has jensen alpha of 0.1803, we advise you to double-check Verve Therapeutics's current market performance to make sure the company can sustain itself at a future point.
Verve Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Verve, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VerveVerve |
Verve Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 44.22 | Strong Buy | 10 | Odds |
Most Verve analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Verve stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Verve Therapeutics, talking to its executives and customers, or listening to Verve conference calls.
Verve Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Verve Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Verve Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Verve Therapeutics Trend Analysis
Use this graph to draw trend lines for Verve Therapeutics. You can use it to identify possible trend reversals for Verve Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Verve Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Verve Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Verve Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.02 , which means Verve Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 22.74, which is the sum of squared deviations for the predicted Verve Therapeutics price change compared to its average price change.About Verve Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Verve Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Verve Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Verve Therapeutics price pattern first instead of the macroeconomic environment surrounding Verve Therapeutics. By analyzing Verve Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Verve Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Verve Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Payables Turnover | 0.82 | 0.78 | Days Of Inventory On Hand | 4.9E-5 | 4.3E-5 |
Verve Therapeutics December 14, 2024 Technical Indicators
Most technical analysis of Verve help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Verve from various momentum indicators to cycle indicators. When you analyze Verve charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0396 | |||
| Market Risk Adjusted Performance | 0.3851 | |||
| Mean Deviation | 4.01 | |||
| Semi Deviation | 4.26 | |||
| Downside Deviation | 4.48 | |||
| Coefficient Of Variation | 2347.71 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.7 | |||
| Information Ratio | 0.0254 | |||
| Jensen Alpha | 0.1803 | |||
| Total Risk Alpha | (0.48) | |||
| Sortino Ratio | 0.0329 | |||
| Treynor Ratio | 0.3751 | |||
| Maximum Drawdown | 35.47 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 9.07 | |||
| Downside Variance | 20.06 | |||
| Semi Variance | 18.18 | |||
| Expected Short fall | (4.66) | |||
| Skewness | 1.69 | |||
| Kurtosis | 6.6 |
Additional Tools for Verve Stock Analysis
When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.